𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retinoid-responsive transcriptional changes in epidermal keratinocytes

✍ Scribed by Ding-Dar Lee; Olivera Stojadinovic; Agata Krzyzanowska; Constantinos Vouthounis; Miroslav Blumenberg; Marjana Tomic-Canic


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
401 KB
Volume
220
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Retinoids (RA) have been used as therapeutic agents for numerous skin diseases, from psoriasis to acne and wrinkles. While RA is known to inhibit keratinocyte differentiation, the molecular effects of RA in epidermis have not been comprehensively defined. To identify the transcriptional targets of RA in primary human epidermal keratinocytes, we compared the transcriptional profiles of cells grown in the presence or absence of all‐trans retinoic acid for 1, 4, 24, 48, and 72 h, using large DNA microarrays. As expected, RA suppresses the protein markers of cornification; however the genes responsible for biosynthesis of epidermal lipids, long‐chain fatty acids, cholesterol, and sphingolipids, are also suppressed. Importantly, the pathways of RA synthesis, esterification and metabolism are activated by RA; therefore, RA regulates its own bioavailability. Unexpectedly, RA regulates many genes associated with the cell cycle and programmed cell death. This led us to reveal novel effects of RA on keratinocyte proliferation and apoptosis. The response to RA is very fast: 315 genes were regulated already after 1 h. More than one‐third of RA‐regulated genes function in signal transduction and regulation of transcription. Using in silico analysis, we identified a set of over‐represented transcription factor binding sites in the RA‐regulated genes. Many psoriasis‐related genes are regulated by RA, some induced, others suppressed. These results comprehensively document the transcriptional changes caused by RA in keratinocytes, add new insights into the molecular mechanism influenced by RA in the epidermis and demonstrate the hypothesis‐generating power of DNA microarray analysis. J. Cell. Physiol. 220: 427–439, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Transcriptional profiling defines the ef
✍ Alix Gazel; Martin Rosdy; Carine Tornier; Anne De Brugerolle De Fraissinette; Mi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

## Abstract Nickel is a ubiquitous and virtually unavoidable environmental pollutant and occupational hazard, but its molecular and cellular effects are not well understood. Human epidermal keratinocytes are the sentinel and the primary target for nickel. We treated with nickel salts skin equivalen

Transcriptional profiling defines the ro
✍ Alix Gazel; Rajiv I. Nijhawan; Rebecca Walsh; Miroslav Blumenberg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

## Abstract Epidermal keratinocytes respond to extracellular influences by activating cytoplasmic signal transduction pathways that change gene expression. Using pathway‐specific transcriptional profiling, we identified the genes regulated by two such pathways, p38 and ERK. These pathways are at th

PAI-1 transcriptional regulation during
✍ Li Qi; Rosalie R. Allen; Qi Lu; Craig E. Higgins; Rosemarie Garone; Lisa Staiano 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

## Abstract Plasminogen activator inhibitor type‐1 (PAI‐1) is the major negative regulator of the plasmin‐dependent pericellular proteolytic cascade. PAI‐1 gene expression is normally growth state regulated but frequently elevated in chronic fibroproliferative and neoplastic diseases affecting both

Upstream stimulatory factor regulates E
✍ Rosalie R. Allen; Li Qi; Paul J. Higgins 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

## Abstract Certain growth factors (e.g., TGF‐β1) initiate a “plastic” response in human keratinocytes (HaCaT cells) characterized by changes in gene expression and increased cell motility. While microarray analyses identified a number of involved genes, plasminogen activator inhibitor type 1 (__PA